Annual EBIT
-$95.29 M
+$42.62 M+30.90%
December 31, 2022
Summary
- As of February 10, 2025, FRLN annual earnings before interest & taxes is -$95.29 million, with the most recent change of +$42.62 million (+30.90%) on December 31, 2022.
- During the last 3 years, FRLN annual EBIT has fallen by -$42.24 million (-79.62%).
Performance
FRLN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$12.03 M
+$5.47 M+31.28%
September 1, 2023
Summary
- As of February 10, 2025, FRLN quarterly earnings before interest & taxes is -$12.03 million, with the most recent change of +$5.47 million (+31.28%) on September 1, 2023.
- Over the past year, FRLN quarterly EBIT has increased by +$10.90 million (+47.53%).
Performance
FRLN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$64.03 M
+$10.90 M+14.54%
September 1, 2023
Summary
- As of February 10, 2025, FRLN TTM earnings before interest & taxes is -$64.03 million, with the most recent change of +$10.90 million (+14.54%) on September 1, 2023.
- Over the past year, FRLN TTM EBIT has increased by +$44.64 million (+41.08%).
Performance
FRLN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FRLN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | +47.5% | +41.1% |
| 3 y3 years | -79.6% | +51.6% | -8.4% |
| 5 y5 years | -187.8% | - | - |
FRLN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | at high | +161.1% | at high | +115.4% |
| 5 y | 5-year | +79.6% | +44.7% | at high | +218.9% | +266.1% | +115.4% |
| alltime | all time | +187.8% | +44.7% | at high | +218.9% | +266.1% | +115.4% |
Freeline Therapeutics Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$12.03 M(-31.3%) | -$64.03 M(-14.5%) |
| Jun 2023 | - | -$17.50 M(+6.2%) | -$74.93 M(-10.8%) |
| Mar 2023 | - | -$16.48 M(-8.6%) | -$83.98 M(-11.9%) |
| Dec 2022 | -$95.29 M(-30.9%) | -$18.02 M(-21.4%) | -$95.29 M(-12.3%) |
| Sep 2022 | - | -$22.92 M(-13.7%) | -$108.67 M(-9.9%) |
| Jun 2022 | - | -$26.56 M(-4.4%) | -$120.55 M(-8.9%) |
| Mar 2022 | - | -$27.79 M(-11.5%) | -$132.35 M(-4.0%) |
| Dec 2021 | -$137.91 M | - | - |
| Dec 2021 | - | -$31.40 M(-9.8%) | -$137.91 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$34.81 M(-9.3%) | -$134.62 M(+8.0%) |
| Jun 2021 | - | -$38.35 M(+15.0%) | -$124.66 M(+21.0%) |
| Mar 2021 | - | -$33.34 M(+18.6%) | -$103.03 M(+18.2%) |
| Dec 2020 | -$87.18 M(+64.3%) | - | - |
| Dec 2020 | - | -$28.12 M(+13.2%) | -$87.18 M(+47.6%) |
| Sep 2020 | - | -$24.85 M(+48.6%) | -$59.06 M(+72.6%) |
| Jun 2020 | - | -$16.73 M(-4.4%) | -$34.21 M(+95.6%) |
| Mar 2020 | - | -$17.49 M | -$17.49 M |
| Dec 2019 | -$53.05 M(+60.2%) | - | - |
| Dec 2018 | -$33.10 M | - | - |
FAQ
- What is Freeline Therapeutics Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings annual EBIT year-on-year change?
- What is Freeline Therapeutics Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings quarterly EBIT year-on-year change?
- What is Freeline Therapeutics Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings TTM EBIT year-on-year change?
What is Freeline Therapeutics Holdings annual earnings before interest & taxes?
The current annual EBIT of FRLN is -$95.29 M
What is the all time high annual EBIT for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high annual earnings before interest & taxes is -$33.10 M
What is Freeline Therapeutics Holdings annual EBIT year-on-year change?
Over the past year, FRLN annual earnings before interest & taxes has changed by +$42.62 M (+30.90%)
What is Freeline Therapeutics Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of FRLN is -$12.03 M
What is the all time high quarterly EBIT for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high quarterly earnings before interest & taxes is -$12.03 M
What is Freeline Therapeutics Holdings quarterly EBIT year-on-year change?
Over the past year, FRLN quarterly earnings before interest & taxes has changed by +$10.90 M (+47.53%)
What is Freeline Therapeutics Holdings TTM earnings before interest & taxes?
The current TTM EBIT of FRLN is -$64.03 M
What is the all time high TTM EBIT for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high TTM earnings before interest & taxes is -$17.49 M
What is Freeline Therapeutics Holdings TTM EBIT year-on-year change?
Over the past year, FRLN TTM earnings before interest & taxes has changed by +$44.64 M (+41.08%)